LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE 1/2 CLINICAL DATA OF LX2006 FOR THE TREATMENT OF FRIEDREICH ATAXIA CARDIOMYOPATHY.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    ENP Newswire. July 16, 2024.